MedTrace Logo

Standardization of Multi-modal Tumor Ablation Therapy System

NCT03223142 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-07-21

No results posted yet for this study

Summary

This study will document for the safety and efficacy of image guided multi-mode precision ablation system (the combination of cryoablation and radiofrequency ablation) for the treatment of liver malignant, as well as provide the indicator of antitumor immune response for liver malignant in China.

Conditions

  • Liver Neoplasms
  • Ablation Techniques
  • Cryoablation
  • Safety
  • Treatment Outcome
  • Neoplasm Metastasis
  • Clinical Trial

Interventions

DEVICE

Multi-modal Precision Ablation

In Multi-modal Precision Ablation group, patients received Image-guided cryoablation immediately followed by radiofrequency ablation

Sponsors & Collaborators

  • Fudan University

    collaborator OTHER

  • Ruijin Hospital

    collaborator OTHER

  • Changhai Hospital

    collaborator OTHER

  • Shanghai Jiao Tong University Affiliated Sixth People's Hospital

    collaborator OTHER

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Lisaxu Xu, MD. PhD. · Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-31
Primary Completion
2019-12-31
Completion
2020-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03223142 on ClinicalTrials.gov